Table 1 Clinical characteristics of the study population.

From: Association of S100B polymorphisms and serum S100B with risk of ischemic stroke in a Chinese population

Variables

Controls (n = 398)

IS patients (n = 396)

P value

Age, years (mean ± SD)

58.09 ± 8.76

59.16 ± 9.18

0.093

Gender (M/F)

231/167

252/144

0.106

Hypertension, n (%)

88 (22.1%)

161 (40.6%)

<0.001

Diabetes mellitus, n (%)

41 (10.3%)

64 (16.2%)

0.015

Smoker, n (%)

62 (15.6%)

116 (29.3%)

<0.001

TCH, mmol/L

4.84 ± 0.74

4.78 ± 1.23

0.390

TG, mmol/L

1.24 ± 0.74

1.60 ± 1.09

<0.001

HDL-C, mmol/L

1.66 ± 0.39

1.26 ± 0.35

<0.001

LDL-C, mmol/L

2.47 ± 0.56

2.64 ± 0.89

<0.001

VLDL-C, mmol/L

0.57 ± 0.36

0.73 ± 0.49

<0.001

  1. IS, ischemic stroke; SD, standard deviation; M, male; F, female; TCH, total cholesterol; TG, triglyceride; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; VLDL-C, very low density lipoprotein-cholesterol.
Back to article page